Cell-by-cell in-vivo repair
Machinery that works through a body cell by cell, diagnosing and physically restoring damaged structures - the premise behind nanomedical repair and revival from preservation.
State of the art
The nearest real capabilities are single-trigger DNA-origami devices acting on tumor cells in mice (2024) and biology's own repair machinery; no device has repaired an injured cell's internal structure.
- No way to read the internal state of a living cell without destroying it
- A human body has roughly 3x10^13 cells, so any per-cell procedure needs a throughput no proposed system approaches
- Molecular-scale positional control in a warm, crowded, aqueous environment is unsolved
- Energy supply and waste handling for billions of simultaneously operating devices is unaddressed
Who’s working on it
- Wei GaoResearcherCalifornia Institute of Technology
Built bioresorbable acoustic microrobots that were ultrasound-tracked and magnetically steered to shrink bladder tumours in mice (Science Robotics, 2024), then simplified them into self-targeting bubble bots (Nature Nanotechnology, February 2026)
- Bjoern HoegbergResearcherKarolinska Institutet
Builds DNA origami devices that hide a cytotoxic peptide pattern until a tumour's acidic pH triggers display, killing tumour cells in mice (2024) - the closest thing to a conditional molecular machine acting in a body
- Bradley NelsonResearcherMulti-Scale Robotics Lab, ETH Zurich
Long-running program on magnetically actuated micro- and nanorobots and the control and imaging needed to steer them through real tissue
- Hao YanResearcherBiodesign Center for Molecular Design and Biomimetics, Arizona State University
Pioneer of programmable DNA origami architectures, including origami nanostructures used as triggerable drug carriers in animal models
- Bionaut LabsStartup
Los Angeles company developing magnetically steered millimetre-scale devices to carry payloads to CNS targets; the only venture-funded attempt at externally guided in-body machines
- National Nanotechnology InitiativeProgram
US cross-agency program (roughly $1.8B a year) that funds the nanoscale fabrication, actuation and characterisation base any cell-scale repair device would need
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Programs on non-destructive single-cell internal-state readout, the prerequisite for any targeted repair | $$ $10M – $100M |
| research | Systems-level analysis of a repair pipeline for one well-defined injury (ischemic neuron) to identify the blocking subsystem | $ < $10M |
Depends on
Required by
No other capability builds on this directly.